Bvf Inc Allakos Inc. Transaction History

Bvf Inc

$3.15 Billion
Q3 2024

A detailed history of Bvf Inc transactions in Allakos Inc. stock. As of the latest transaction made, Bvf Inc holds 16,552,417 shares of ALLK stock, worth $21.4 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

16,552,417

Previous 16,552,417 -0.0%

Holding current value

$21.4 Million

Previous $16.6 Million 35.0%

% of portfolio

0.34%

Previous 0.51%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.02 - $3.23 $8.16 Million - $25.8 Million	8,000,000 Added 93.54%	16,552,417 $20.9 Million
Q3 2023 Nov 14, 2023	SELL	$2.13 - $5.55 $213,000 - $555,000	-100,000 Reduced 1.16%	8,552,417 $19.4 Million
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $9.33 Million - $13.6 Million	2,592,170 Added 42.77%	8,652,417 $37.7 Million
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $4.53 Million - $8.71 Million	1,053,326 Added 21.04%	6,060,247 $27 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $15.1 Million - $30.6 Million	5,006,921 New	5,006,921 $30.6 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $109M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account